CALPOL SASE PLUS 250mg/5ml oral suspension GLAXO SMITH KLINE
Active substance: paracetamol
N02BE01 Nervous system | Other analgesics and antipyretics | Anilides
Indicated for: pain; fever
Find medicines for human use by name or active substance.
Browse by initial
81–100 of 1,627 medicines
Active substance: paracetamol
N02BE01 Nervous system | Other analgesics and antipyretics | Anilides
Indicated for: pain; fever
Active substance: paracetamol
N02BE01 Nervous system | Other analgesics and antipyretics | Anilides
Indicated for: pain; fever
Active substance: acalabrutinib
Indicated for: hematologic malignancies
Active substance: acalabrutinib
Indicated for: hematologic malignancies
Active substance: calcium chloride
B05XA07 Blood and blood forming organs | I.v. solution additives | Electrolyte solutions
Indicated for: calcium deficiency; osteoporosis
Active substance: combinations
Indicated for: various therapeutic indications
Active substance: bicalutamide
Indicated for: prostate cancer
Active substance: ketamine
N01AX03 Nervous system | Anesthetics | Anesthetics, general | Other general anesthetics
Indicated for: general anesthesia; procedural sedation
Active substance: ketamine
N01AX03 Nervous system | Anesthetics | Anesthetics, general | Other general anesthetics
Indicated for: general anesthesia; procedural sedation
Active substance: leuprorelin
Indicated for: prostate cancer; breast cancer; endometriosis
Active substance: homeopathic
Indicated for: homeopathic use
Active substance: salmeterol + fluticasone
Indicated for: asthma; chronic obstructive pulmonary disease
Active substance: salmeterol + fluticasone
Indicated for: asthma; chronic obstructive pulmonary disease
Active substance: salmeterol + fluticasone
Indicated for: asthma; chronic obstructive pulmonary disease
Active substance: irinotecan
L01XX19 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: colorectal cancer
Active substance: irinotecan
L01XX19 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: colorectal cancer
Active substance: mavacamten
C01EB24 Cardiovascular system | Other cardiac preparations
Indicated for: obstructive hypertrophic cardiomyopathy
Active substance: mavacamten
C01EB24 Cardiovascular system | Other cardiac preparations
Indicated for: obstructive hypertrophic cardiomyopathy
Active substance: mavacamten
C01EB24 Cardiovascular system | Other cardiac preparations
Indicated for: obstructive hypertrophic cardiomyopathy
Active substance: mavacamten
C01EB24 Cardiovascular system | Other cardiac preparations
Indicated for: obstructive hypertrophic cardiomyopathy
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.